City State Bank’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.03K Hold
150
﹤0.01% 693
2026
Q1
$2.94K Hold
150
﹤0.01% 664
2025
Q4
$4.02K Hold
150
﹤0.01% 629
2025
Q3
$4K Hold
150
﹤0.01% 615
2025
Q2
$3.44K Hold
150
﹤0.01% 634
2025
Q1
$4.35K Hold
150
﹤0.01% 603
2024
Q4
$5.57K Hold
150
﹤0.01% 557
2024
Q3
$7.28K Hold
150
﹤0.01% 528
2024
Q2
$6K Hold
150
﹤0.01% 536
2024
Q1
$7K Buy
+150
New +$7.75K ﹤0.01% 519
2023
Q4
Sell
-100
Closed -$5K 682
2023
Q3
$5K Buy
+100
New +$5.46K ﹤0.01% 544
2023
Q2
Sell
-100
Closed -$4K 704
2023
Q1
$4K Hold
100
﹤0.01% 569
2022
Q4
$3K Hold
100
﹤0.01% 565
2022
Q3
$2K Hold
100
﹤0.01% 590
2022
Q2
$3K Sell
100
-50
-33% -$1.78K ﹤0.01% 567
2022
Q1
$5K Hold
150
﹤0.01% 548
2021
Q4
$3K Buy
+150
New +$3.07K ﹤0.01% 575

Other funds holding AMPH

City State Bank's AMPH Position: Q2 2026 in Review

City State Bank held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2026 at 150 shares worth $3.03K. The position accounts for ﹤0.01% of the portfolio, ranked #693.

City State Bank first reported a position in AMPH in Q4 2021 and has held it in 17 quarters since. The position peaked at $7.28K in Q3 2024. 20 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • City State Bank held 150 shares of Amphastar Pharmaceuticals worth $3.03K as of Q2 2026.
  • City State Bank left its Amphastar Pharmaceuticals share count unchanged in Q2 2026.
  • Amphastar Pharmaceuticals made up ﹤0.01% of City State Bank's portfolio in Q2 2026, its #693 holding.
  • City State Bank first reported a position in Amphastar Pharmaceuticals in Q4 2021 and has held it in 17 quarters since.
  • City State Bank's Amphastar Pharmaceuticals position peaked at $7.28K in Q3 2024.
  • 20 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.